Covid 19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: subcutaneous injection of Recigen (44mcg) daily until 5 days or the discharge day (which ever come sooner) in addition to standard treatment (based on the Ministry
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: patients who are diagnosed to have covid-19 based on Chest Ct Scan patients being admitted to emergency room based on local guidelines age 18 years or loder
Exclusion criteria
Exclusion criteria: pregnancy breast feeding do not consent to be in this study allergies to interferon not having a proper phone number for follow up calls
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hospital stay. Timepoint: discharge date. Method of measurement: checklist.;Need for ICU admission. Timepoint: discharge date. Method of measurement: check list based on treating clinicians judgment.;Need for intubation. Timepoint: discharge date. Method of measurement: check list based on treating clinicians judgment. | — |
Secondary
| Measure | Time frame |
|---|---|
| O2 saturation. Timepoint: daily. Method of measurement: pulse oxymeter.;Fever. Timepoint: daily. Method of measurement: thermometer.;Side effects. Timepoint: daily. Method of measurement: check list based on treating clinicians judgment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactPooya Payandemehr
Tehran University of Medical Sciences
Outcome results
None listed